Literature DB >> 16519680

Kinetic study of the HIV-1 DNA 3'-end processing.

Maksim Smolov1, Marina Gottikh, Vadim Tashlitskii, Sergei Korolev, Ilya Demidyuk, Jean-Claude Brochon, Jean-François Mouscadet, Eric Deprez.   

Abstract

The 3'-processing of viral DNA extremities is the first step in the integration process catalysed by human immunodeficiency virus (HIV)-1 integrase (IN). This reaction is relatively inefficient and processed DNAs are usually detected in vitro under conditions of excess enzyme. Despite such experimental conditions, steady-state Michaelis-Menten formalism is often applied to calculate characteristic equilibrium/kinetic constants of IN. We found that the amount of processed product was not significantly affected under conditions of excess DNA substrate, indicating that IN has a limited turnover for DNA cleavage. Therefore, IN works principally in a single-turnover mode and is intrinsically very slow (single-turnover rate constant = 0.004 min(-1)), suggesting that IN activity is mainly limited at the chemistry step or at a stage that precedes chemistry. Moreover, fluorescence experiments showed that IN-DNA product complexes were very stable over the time-course of the reaction. Binding isotherms of IN to DNA substrate and product also indicate tight binding of IN to the reaction product. Therefore, the slow cleavage rate and limited product release prevent or greatly reduce subsequent turnover. Nevertheless, the time-course of product formation approximates to a straight line for 90 min (apparent initial velocity), but we show that this linear phase is due to the slow single-turnover rate constant and does not indicate steady-state multiple turnover. Finally, our data ruled out the possibility that there were large amounts of inactive proteins or dead-end complexes in the assay. Most of complexes initially formed were active although dramatically slow.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16519680     DOI: 10.1111/j.1742-4658.2006.05139.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  17 in total

1.  Biochemical analysis of HIV-1 integrase variants resistant to strand transfer inhibitors.

Authors:  Ira B Dicker; Brian Terry; Zeyu Lin; Zhufang Li; Sagarika Bollini; Himadri K Samanta; Volodymyr Gali; Michael A Walker; Mark R Krystal
Journal:  J Biol Chem       Date:  2008-06-24       Impact factor: 5.157

2.  Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo.

Authors:  Olivier Delelis; Sylvain Thierry; Frédéric Subra; Françoise Simon; Isabelle Malet; Chakib Alloui; Sophie Sayon; Vincent Calvez; Eric Deprez; Anne-Geneviève Marcelin; Luba Tchertanov; Jean-François Mouscadet
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

3.  Characterization of the Drug Resistance Profiles of Integrase Strand Transfer Inhibitors in Simian Immunodeficiency Virus SIVmac239.

Authors:  Said A Hassounah; Yannan Liu; Peter K Quashie; Maureen Oliveira; Daniela Moisi; Bluma G Brenner; Paul A Sandstrom; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

4.  Differential effects of the G118R, H51Y, and E138K resistance substitutions in different subtypes of HIV integrase.

Authors:  Peter K Quashie; Maureen Oliviera; Tamar Veres; Nathan Osman; Ying-Shan Han; Said Hassounah; Yolanda Lie; Wei Huang; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

5.  Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution.

Authors:  Mark D Andrake; Joseph Ramcharan; George Merkel; Xue Zhi Zhao; Terrence R Burke; Anna Marie Skalka
Journal:  AIDS Res Ther       Date:  2009-06-29       Impact factor: 2.250

6.  A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain.

Authors:  Kevin Carayon; Hervé Leh; Etienne Henry; Françoise Simon; Jean-François Mouscadet; Eric Deprez
Journal:  Nucleic Acids Res       Date:  2010-02-17       Impact factor: 16.971

Review 7.  Oligonucleotide-based assays for integrase activity.

Authors:  George Merkel; Mark D Andrake; Joseph Ramcharan; Anna Marie Skalka
Journal:  Methods       Date:  2008-11-14       Impact factor: 3.608

8.  Biochemical analysis of the role of G118R-linked dolutegravir drug resistance substitutions in HIV-1 integrase.

Authors:  Peter K Quashie; Thibault Mesplède; Ying-Shan Han; Tamar Veres; Nathan Osman; Said Hassounah; Richard D Sloan; Hong-Tao Xu; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

9.  Efficient antifouling surface for quantitative surface plasmon resonance based biosensor analysis.

Authors:  Claude Nogues; Hervé Leh; Joseph Lautru; Olivier Delelis; Malcolm Buckle
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

Review 10.  Integrase and integration: biochemical activities of HIV-1 integrase.

Authors:  Olivier Delelis; Kevin Carayon; Ali Saïb; Eric Deprez; Jean-François Mouscadet
Journal:  Retrovirology       Date:  2008-12-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.